Intrexon | XON - 应收帐款人





应收帐款人 更改 日
Agenus USD 22.44M 1.14M 2025-12
Alaunos Therapeutics USD 2K 0 2025-06
Amgen USD 9.14B 432M 2026-03
Anika Therapeutics USD 29.33M 661K 2025-12
Arrowhead Research USD 15.68M 203.19M 2026-03
AstraZeneca USD 17.88B 1.17B 2026-03
Bristol-Myers Squibb USD 14.36B 164M 2026-03
Gilead Sciences USD 4.74B 172M 2026-03
GlaxoSmithKline GBP 7.94B 178M 2026-03
Heron Therapeutics USD 89.59M 8.54M 2025-12
Incyte USD 1.05B 27.09M 2026-03
Intrexon USD 1.02M 559K 2024-06
Karyopharm Therapeutics USD 26.18M 5.6M 2025-12
Ligand Pharmaceuticals USD 54.8M 6.25M 2026-03
MacroGenics USD 13.37M 55.86M 2025-12
MannKind USD 28.14M 10.23M 2026-03
Merck USD 11.78B 345M 2025-12
Novartis USD 9.6B 2.69B 2026-03
Rigel Pharmaceuticals USD 28.9M 1.39M 2024-06
Roche Holding CHF 11.9B 460M 2025-12
Sangamo BioSciences USD 581K 110K 2024-06
Thermo Fisher Scientific USD 9.2B 304M 2026-03
Veracyte USD 50.11M 5.45M 2026-03
Xencor USD 12M 17.3M 2026-03